Multiconsult

Multiconsult Group reported a 7.8% revenue increase in Q2 2026, an improved EBITDA margin from 4.8% to 7.8% and a significantly higher EPS from 1.45 to 3.23 NOK. Organic growth remained weak at 0.7%; capacity adjustments were announced due to unsatisfactory utilization. Framework agreements in defense and healthcare strengthen the order pipeline but partly delay revenue recognition. The shares fell 2.78% to $147 despite rising profitability. » More on de.investing.com

Multiconsult reports Q1 2026 EPS of $4, missing the consensus expectation of $4.45 (‑10.11%). Revenue was NOK 1.61 billion (forecast NOK 1.62 billion) and rose 5.5% year‑on‑year thanks to organic growth and M&A. Operating and personnel costs increased markedly, EBITDA margin was 10% (calendar‑adjusted 12.4%), and operating cash flow was positive at NOK 136 million. The share fell slightly by 0.63% after the results; management confirms a stable outlook and is focusing on digital infrastructure, urban transformation and margin improvement through 2027. » More on de.investing.com

Multiconsult reports net operating revenue of NOK 1,608.0m (+5.5%) for Q1 2026, while EBITA fell 15.7% to NOK 160.5m and the EBITA margin declined from 12.5% to 10.0%. Organic growth and higher billing rates were weighed down by calendar effects, increased personnel costs and slightly lower utilisation. Order intake rose 4.9% to NOK 1,779m, but the order backlog fell 13.6% to NOK 4,102m. Net interest-bearing liabilities increased to NOK 697m; management emphasizes cost-control measures and is focusing on energy, defence and infrastructure projects. » More on de.investing.com